Workflow
False Claims Act
icon
Search documents
SLQT Stockholders with Large Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the SelectQuote, Inc. Class Action
GlobeNewswire News Room· 2025-08-22 23:14
SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025. SelectQuote is an insurance broker which sells Medicare Advantage and other health insurance plans online and by telephone. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SelectQuote, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLQT
GlobeNewswire News Room· 2025-08-21 15:36
Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. concerning allegations of securities fraud and unlawful business practices [1][2] Group 1: Lawsuit Details - The class action lawsuit involves claims that SelectQuote and its officers engaged in securities fraud or other unlawful business practices [2] - Investors have until October 10, 2025, to request to be appointed as Lead Plaintiff if they purchased SelectQuote securities during the Class Period [2] Group 2: Allegations by the DOJ - On May 1, 2025, the U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021 [4] - The DOJ claims SelectQuote conspired with major insurers to discriminate against less profitable beneficiaries, including those with disabilities [4] - SelectQuote allegedly made materially false claims about offering "unbiased coverage comparisons," directing Medicare beneficiaries to plans that paid them the most money [4] - Following the DOJ's announcement, SelectQuote's stock price fell by $0.61 per share, or 19.24%, closing at $2.56 per share on May 1, 2025 [4]
SELECTQUOTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against SelectQuote, Inc. and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-08-12 23:53
Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. due to allegations of receiving illegal kickbacks from health insurance companies and misleading Medicare beneficiaries [1][3][4]. Group 1: Legal Allegations - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurance plans [3]. - The complaint claims that SelectQuote made materially false statements regarding its services, asserting it provided unbiased coverage comparisons while actually directing beneficiaries to the most profitable plans for the company [4]. - SelectQuote is accused of failing to disclose significant adverse facts about its business practices, including directing beneficiaries to plans based on compensation rather than quality [4]. Group 2: Financial Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [3]. Group 3: Investor Actions - Investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, are encouraged to contact Bragar Eagel & Squire for potential legal recourse [1][5]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 10, 2025 [1].
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Humana Inc. (NYSE: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-06-06 22:13
Company Overview - Humana Inc. is a for-profit health insurance company that provides Medicare Advantage, individual and group insurance, pharmacy benefit management, and integrated care services through its CenterWell network [3] Allegations of Wrongdoing - The Department of Justice filed a False Claims Act complaint against Humana on May 1, 2025, alleging that from 2016 to at least 2021, the company paid illegal kickbacks to health insurance brokers for enrollments into its Medicare Advantage plans [4] Market Reaction - Following the announcement of the DOJ lawsuit, Humana's stock price fell by $6.20 per share, or 2.36%, closing at $256.04 per share on May 1, 2025 [5]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR
GlobeNewswire News Room· 2025-05-28 22:19
Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1]. Group 1: Company Disclosure - On February 28, 2025, Semler filed its annual report for 2024, indicating a risk of a complaint from the U.S. Department of Justice (DOJ) related to a civil False Claims Act lawsuit [3]. - Semler disclosed receiving an initial civil investigative demand from the DOJ in July 2017 concerning reimbursement claims for its QuantaFlo device [3]. - The company participated in unsuccessful settlement discussions with the DOJ in February 2025 [3]. Group 2: Market Reaction - Following the news of the DOJ investigation, Semler's stock price dropped by $4.03 per share, or 9.4%, closing at $38.89 per share on March 3, 2025 [4].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
GlobeNewswire News Room· 2025-05-09 13:00
Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving Humana Inc. following a lawsuit filed by the U.S. Department of Justice alleging illegal kickbacks related to Medicare Advantage plans [1][3]. Group 1: Investigation and Legal Actions - Pomerantz LLP is representing investors of Humana Inc. in an investigation concerning possible securities fraud or unlawful business practices by the company and its officers [1]. - The U.S. Department of Justice filed a False Claims Act complaint against Humana and other health insurance companies, alleging that from 2016 to 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [3]. - Following the DOJ's lawsuit announcement, Humana's stock price decreased by $6.20 per share, or 2.36%, closing at $256.04 on May 1, 2025 [3]. Group 2: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in fighting for victims of securities fraud and corporate misconduct [4].
SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations - Hagens Berman
Prnewswire· 2025-05-09 12:21
Core Viewpoint - SelectQuote's stock price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage sector [1][3]. Company Investigation - Hagens Berman is investigating SelectQuote for potential misconduct regarding its sales practices and disclosures, particularly in its Senior business that offers Medicare Advantage plans [2][4]. - The investigation is focused on whether SelectQuote's claims of providing unbiased advice and comparison shopping for Medicare plans were misleading [3][4]. Allegations Against SelectQuote - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other brokers received substantial payments from insurers for enrollments into Medicare Advantage plans, which may have influenced their sales practices [7]. - It is claimed that SelectQuote directed beneficiaries to plans that provided the highest kickbacks, rather than those that were most suitable for the beneficiaries [7]. - The company allegedly incentivized employees to prioritize plans based on kickbacks and discriminated against Medicare Advantage beneficiaries with disabilities [7].
GOHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating GoHealth, Inc. on Behalf of GoHealth Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-09 01:00
Core Viewpoint - GoHealth, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following a False Claims Act complaint filed by the U.S. Department of Justice against several health insurance companies, including GoHealth [1][2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against GoHealth on behalf of its stockholders [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, GoHealth and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments into Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ's lawsuit, GoHealth's stock price dropped by $1.09 per share, representing a decline of 10.35%, closing at $9.44 per share on May 1, 2025 [2].
SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations – Hagens Berman
GlobeNewswire News Room· 2025-05-07 13:15
Core Viewpoint - SelectQuote's share price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage market [1][3]. Group 1: Lawsuit and Allegations - The U.S. Department of Justice filed a lawsuit against SelectQuote and other insurance brokers, claiming they violated the False Claims Act [1]. - The investigation focuses on SelectQuote's disclosures regarding its sales practices, particularly in its Senior business offering Medicare Advantage plans [2]. - Allegations include that SelectQuote directed Medicare beneficiaries to plans that provided the highest kickbacks to brokers, rather than acting in the best interest of the beneficiaries [5]. Group 2: Financial Impact - Following the announcement of the lawsuit, SelectQuote's shares fell by over 19% on May 1, 2025 [1][3]. - The lawsuit raises concerns about the potential inflation of SelectQuote's financial results due to alleged steering practices [4]. Group 3: Whistleblower Information - Whistleblowers with non-public information regarding SelectQuote are encouraged to assist in the investigation, with potential rewards of up to 30% of any successful recovery made by the SEC [4].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO
GlobeNewswire News Room· 2025-05-05 16:25
Group 1 - Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1] - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth and other health insurance companies, alleging that from 2016 to at least 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments into Medicare Advantage plans [3] - Following the DOJ's lawsuit announcement, GoHealth's stock price dropped by $1.09 per share, a decrease of 10.35%, closing at $9.44 per share on May 1, 2025 [3]